<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Long SW</submitter><funding>National Institute of Allergy and Infectious Diseases</funding><funding>U.S. Department of Health and Human Services</funding><funding>NIAID NIH HHS</funding><funding>National Institutes of Health</funding><pagination>983-992</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC7962948</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>191(6)</volume><pubmed_abstract>Since the beginning of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic, there has been international concern about the emergence of virus variants with mutations that increase transmissibility, enhance escape from the human immune response, or otherwise alter biologically important phenotypes. In late 2020, several variants of concern emerged globally, including the UK variant (B.1.1.7), the South Africa variant (B.1.351), Brazil variants (P.1 and P.2), and two related California variants of interest (B.1.429 and B.1.427). These variants are believed to have enhanced transmissibility. For the South Africa and Brazil variants, there is evidence that mutations in spike protein permit it to escape from some vaccines and therapeutic monoclonal antibodies. On the basis</pubmed_abstract><journal>The American journal of pathology</journal><pubmed_title>Sequence Analysis of 20,453 Severe Acute Respiratory Syndrome Coronavirus 2 Genomes from the Houston Metropolitan Area Identifies the Emergence and Widespread Distribution of Multiple Isolates of All Major Variants of Concern.</pubmed_title><pmcid>PMC7962948</pmcid><funding_grant_id>75N93019C00076</funding_grant_id><pubmed_authors>Musser JM</pubmed_authors><pubmed_authors>Olsen RJ</pubmed_authors><pubmed_authors>Olson R</pubmed_authors><pubmed_authors>Long SW</pubmed_authors><pubmed_authors>Christensen PA</pubmed_authors><pubmed_authors>Pruitt L</pubmed_authors><pubmed_authors>Finkelstein IJ</pubmed_authors><pubmed_authors>Subedi S</pubmed_authors><pubmed_authors>Saavedra MO</pubmed_authors><pubmed_authors>Reppond K</pubmed_authors><pubmed_authors>Shyer MN</pubmed_authors><pubmed_authors>Cambric J</pubmed_authors><pubmed_authors>Davis JJ</pubmed_authors><pubmed_authors>Gollihar J</pubmed_authors><pubmed_authors>Yerramilli P</pubmed_authors></additional><is_claimable>false</is_claimable><name>Sequence Analysis of 20,453 Severe Acute Respiratory Syndrome Coronavirus 2 Genomes from the Houston Metropolitan Area Identifies the Emergence and Widespread Distribution of Multiple Isolates of All Major Variants of Concern.</name><description>Since the beginning of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic, there has been international concern about the emergence of virus variants with mutations that increase transmissibility, enhance escape from the human immune response, or otherwise alter biologically important phenotypes. In late 2020, several variants of concern emerged globally, including the UK variant (B.1.1.7), the South Africa variant (B.1.351), Brazil variants (P.1 and P.2), and two related California variants of interest (B.1.429 and B.1.427). These variants are believed to have enhanced transmissibility. For the South Africa and Brazil variants, there is evidence that mutations in spike protein permit it to escape from some vaccines and therapeutic monoclonal antibodies. On the basis</description><dates><release>2021-01-01T00:00:00Z</release><publication>2021 Jun</publication><modification>2026-04-17T23:42:11.7Z</modification><creation>2021-03-27T08:02:36Z</creation></dates><accession>S-EPMC7962948</accession><cross_references><pubmed>33741335</pubmed><doi>10.1016/j.ajpath.2021.03.004</doi></cross_references></HashMap>